Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo. [electronic resource]
Producer: 20070827Description: 267-73 p. digitalISSN:- 0022-3484
- Animals
- Anticholesteremic Agents -- pharmacology
- Bone Morphogenetic Proteins -- drug effects
- Cyclooxygenase 2 -- drug effects
- Cyclooxygenase 2 Inhibitors -- adverse effects
- Enzyme Inhibitors -- administration & dosage
- NG-Nitroarginine Methyl Ester -- administration & dosage
- Nitric Oxide Synthase -- analysis
- Nitrobenzenes -- administration & dosage
- Osteogenesis -- drug effects
- Rats
- Simvastatin -- pharmacology
- Sulfonamides -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.